Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cavalli

Showing results (141-150 of 350) with videos related to

Pageof 35
Sort By:
Journal of the National Cancer Institute|September 7, 1988
Phase II study of intravenous menogaril in patients with advanced breast cancerC Sessa, S Gundersen, W ten Bokkel Huinink, et al.
Cancer Treatment Reports|March 1, 1985
Phase II evaluation of bisantrene in metastatic breast cancerF Cavalli, B Gerard, W ten Bokkel Huinink, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1985
Phase I trial of 1,2,4-triglycidylurazol (TGU, NSC 332488): a new triepoxide cytostatic agentS W Hansen, F Bach, H H Hansen, et al.
Cancer Treatment Reviews|September 1, 1984
New agents in non-small cell lung cancerR A Joss, F Cavalli, A Goldhirsch, et al.
British Journal of Cancer|January 1, 1997
Clinical relevance of bcl-2(MBR)/J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphomaF Bertoni, G Bosshard, E Roggero, et al.
Leukemia & Lymphoma|April 30, 1999
ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patientsP Saletti, E Zucca, M Gueneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Microsatellite instability: application in hereditary non-polyposis colorectal cancerP Saletti, I D Edwin, K Pack, et al.
Cancer Treatment Reports|March 1, 1978
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedulesF Cavalli, R W Sonntag, F Jungi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescueC Sessa, J de Jong, M D'Incalci, et al.
Tumori|March 1, 1977
A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinomaF Cavalli, E Hasler, H J Ryssel, et al.
Pageof 35

Showing results (141-150 of 350) with videos related to

Sort By:
Pageof 35
Journal of the National Cancer Institute|September 7, 1988
Phase II study of intravenous menogaril in patients with advanced breast cancerC Sessa, S Gundersen, W ten Bokkel Huinink, et al.
Cancer Treatment Reports|March 1, 1985
Phase II evaluation of bisantrene in metastatic breast cancerF Cavalli, B Gerard, W ten Bokkel Huinink, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1985
Phase I trial of 1,2,4-triglycidylurazol (TGU, NSC 332488): a new triepoxide cytostatic agentS W Hansen, F Bach, H H Hansen, et al.
Cancer Treatment Reviews|September 1, 1984
New agents in non-small cell lung cancerR A Joss, F Cavalli, A Goldhirsch, et al.
British Journal of Cancer|January 1, 1997
Clinical relevance of bcl-2(MBR)/J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphomaF Bertoni, G Bosshard, E Roggero, et al.
Leukemia & Lymphoma|April 30, 1999
ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patientsP Saletti, E Zucca, M Gueneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Microsatellite instability: application in hereditary non-polyposis colorectal cancerP Saletti, I D Edwin, K Pack, et al.
Cancer Treatment Reports|March 1, 1978
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedulesF Cavalli, R W Sonntag, F Jungi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescueC Sessa, J de Jong, M D'Incalci, et al.
Tumori|March 1, 1977
A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinomaF Cavalli, E Hasler, H J Ryssel, et al.
Pageof 35